Ontex study finds use of its Orizon digital incontinence care solution can reduce time caregivers spend on incontinence care by 3.2 hours/day; residents had at least eight hours of sleep at night because diapers no longer needed checking for saturation

Sample article from our Tissue & Hygiene

AALST-EREMBODEGEM, Belgium , May 23, 2022 (press release) –

  • Nurses in care homes typically spend nearly half their time on incontinence-related tasks.
  • Ontex’s digital incontinence management field study freed up 3.2 hours of a nursing team’s time per day in the care for 10 patients.
  • Residents no longer had to be woken up several times a night to check diaper saturation, improving residents’ dignity and comfort with a sleep-through policy.

Ontex (Euronext: ONTEX), a leading international provider of personal care solutions, today unveiled the results of a study of its Orizon digital incontinence care solution in a German nursing home.

 

During February and March of 2022, a field study by Ontex at the Palmscher Garten nursing home in the town of Deizisau, Germany, confirmed similar results to that of their earlier pilot projects across Europe. When trialling Orizon on 10 residents at the German nursing home, the time caregivers spent on incontinence care reduced by a total of 3.2 hours a day, and 7 diapers were saved each day. The residents also got at least 8 hours of sleep per night because their diapers no longer required checking for saturation. In nursing homes checking residents through the night is a common routine that means many residents are unnecessarily woken and disturbed during their sleep.

Michael Schildt, director of the nursing home, said, “Orizon has enabled residents to live an even more self-determined life and have a more comfortable daily routine. Especially with incontinence, this is very important for well-being. In addition, colleagues had more time for conversations and encounters – that’s also a big advantage.”

The gain in time and comfort came from the fact that leakages were avoided, saving approximately 10 minutes of 2 nurses per wet bed, incontinence products only needed to be changed when necessary and residents were no longer unnecessarily disturbed at night. It was also noted that no more products leaked during the day or night, eliminating the need for additional bedding changes.

About the field study

Between February 21 and March 18, 2022, Ontex conducted a field study of its Orizon service with the help of 10 nursing home residents and 25 caregivers at the Palmscher Garten nursing home in the town of Deizisau, Germany. The field study helped provide insights into leakage reduction, ease of use and impact on caregivers and residents. The results of the study showed a 100% reduction in daytime and night-time leakage and an overall reduction in the negative impact of leakage, including the elimination of bed linen changes due to urine leakage.

Europe-wide market launch at the turn of the year

In addition to Germany, Ontex has run pilot projects in Belgium and France and will soon start pilot project in Italy and the UK. Ontex plans to launch the digital incontinence management service across Europe in late 2022/early 2023. Ontex launches the service under the new Orizon brand with its incontinence brands Serenity and iD, and will benefit from existing brand recognition and a strong reputation in European nursing homes.

Unlike most of Ontex’s existing incontinence brands and services, Orizon is based on a monthly fee. With the introduction of Orizon, Ontex aims to optimize the overall cost of continence care by reducing waste, linen costs and staff time spent on continence care.

Incontinence: a common condition in the aging population

Incontinence is a very common condition, especially among the elderly in hospitals and nursing homes. Incontinence is one of the most common conditions in elderly care facilities and one of the most important components of facility care costs. Approximately 80% of nursing home residents suffer from some form of incontinence, according to Ontex nursing home order data.

According to research by the World Health Organization[1], between 10% and 36% of people over the age of 60 are affected by incontinence and use incontinence products. Although incontinence is most common in the elderly, all age groups are affected.

The 60+ age group is expected to increase from nearly 1 billion people worldwide [2] today to nearly 2.1 billion by 2050 [3], further straining healthcare systems around the world. Orizon aims to reinvent continence care in partnership with caregivers to make care simpler and easier as the global population ages.

[1] Between 9.9% and 36.1% of the population over 60 years of age is reported to suffer from incontinence. WHO study on incontinence, 2017, page 1, retrieved on May 10th, 2021 https://www.who.int/publications/i/item/WHO-MCA-17.06.08

[2] UN report on ageing population, 2017, page 1 https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf

[3] UN population report, 2015, page 9, retrieved May 10, 2021 https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2015_Report.pdf

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.